Collectively, our findings suggest that PARP7 inhibition induces IRF1- and IRF3-dependent apoptosis by promoting the degradation of FRA1 in FRA1-driven lung and breast cancer cell lines (Fig. 6G). Here, IRF3 is linked to breast carcinoma.